Prosecution Insights
Last updated: October 02, 2026

Examiner: RAMIREZ, DELIA M

Tech Center 1700 • Art Units: 1652 1799

This examiner grants 65% of resolved cases

Analysis

Delia M Ramirez has resolved 853 cases in Tech Center 1700 and Art Unit 1652. The allowance rate is 65.1 percent, showing the likelihood of success for applicants. The median days to allowance is 1025, providing a clear expectation for the duration of the patent acquisition process. These 853 resolved cases provide a robust statistical foundation for these metrics.

A notable statistic is the interview lift of 56.3 percent. This lift suggests that interviews are a transformative tool for prosecution with this examiner. While the baseline allowance rate is 65.1 percent, the 56.3 percent lift indicates that cases are frequently moved toward allowance through direct engagement. With 853 resolved cases, this trend is well-supported, making interviews a primary recommendation for practitioners in Art Unit 1652. The 1025-day median pendency can be managed more effectively by leveraging this 56.3 percent lift.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

65.1%
Allow Rate
At TC average
902
Total Applications
+56.3%
Interview Lift
1025
Avg Prosecution Days
Based on 855 resolved cases, 2023–2026

Rejection Statute Breakdown

7.0%
§101 Eligibility
19.5%
§102 Novelty
21.9%
§103 Obviousness
37.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18697962 CORYNEBACTERIUM GENUS MICROORGANISM PRODUCING L-ARGININE, AND METHOD FOR PRODUCING L-ARGININE USING SAME Non-Final OA CJ CHEILJEDANG CORPORATION
18402269 DECOLORIZING COMPOSITION INCLUDING DICYANDIAMIDE AND HYDROGEN PEROXIDE AND DECOLORIZING METHOD USING THE SAME Final Rejection CJ CHEILJEDANG CORPORATION
17786913 BIOSYNTHETIC PLATFORM FOR THE PRODUCTION OF CANNABINOIDS AND OTHER PRENYLATED COMPOUNDS Non-Final OA The Regents of the University of California
19016469 NOVEL RNA-PROGRAMMABLE ENDONUCLEASE SYSTEMS AND USES THEREOF Non-Final OA BAYER HEALTHCARE LLC
17998703 IMPROVED METHOD FOR THE PRODUCTION OF ISOPRENOIDS Non-Final OA BASF SE
17459166 ENGINEERED PROTEINS AND METHODS OF USE THEREOF Final Rejection Pairwise Plants Services, Inc.
16973061 CRISPR EFFECTOR SYSTEM BASED AMPLIFICATION METHODS, SYSTEMS, AND DIAGNOSTICS Non-Final OA PRESIDENT AND FELLOWS OF HARVARD COLLEGE
17263885 IMPROVED TRANSAMINASE PROTEINS Non-Final OA BAYER AKTIENGESELLSCHAFT
18726717 HEMOSTATIC COMPOSITION CONTAINING RECOMBINANT HUMAN CLOTTING FACTORS, AND METHOD OF PRODUCING Non-Final OA REGENTS OF THE UNIVERSITY OF MINNESOTA
18251604 A CELL-FREE BIO-MANUFACTURING PLATFORM FOR PRODUCTION OF FATTY ACIDS AND CANNABINOIDS Non-Final OA Northwestern University
17396381 COMPOSITIONS AND METHODS FOR CONVERTING STYRENE TO BIODEGRADABLE ALTERNATIVES Non-Final OA University of Virginia Patent Foundation
18306960 GENETIC MANIPULATION METHOD IN BACTERIA Non-Final OA University of Washington
18002251 COMPOSITIONS COMPRISING AROMATIC DIPEPTIDES-BASED STRUCTURES ENCAPSULATING AN ESTERASE AND USES THEREOF Final Rejection Ramot at Tel-Aviv University Ltd.
18035610 METHOD FOR ENZYMATIC OXIDATION OF SULFINIC ACIDS TO SULFONIC ACIDS Non-Final OA WACKER CHEMIE AG
18757644 CELLS COMPRISING MOGROSIDE PATHWAY ENZYMES AND USES THEREOF Non-Final OA The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization
18242912 MICROORGANISMS AND METHODS FOR THE PRODUCTION OF BIOSYNTHESIZED TARGET PRODUCTS HAVING REDUCED LEVELS OF BYPRODUCTS Final Rejection Genomatica, Inc.
17996921 ENGINEERED ENZYMES AND METHODS OF MAKING AND USING Final Rejection Genomatica, Inc.
17819100 Dynamic control over multiple host proteases in a genetically modifiel microorganism Non-Final OA Duke University
16450825 NOVEL CRISPR ENZYMES AND SYSTEMS Non-Final OA The United States of America, as Represented by the Secretary, Dept. of Health and Human Services
16450699 NOVEL CRISPR ENZYMES AND SYSTEMS Final Rejection The United States of America, as Represented by the Secretary, Dept. of Health and Human Services
16450852 NOVEL CRISPR ENZYMES AND SYSTEMS Non-Final OA The United States of America, as Represented by the Secretary, Dept. of Health and Human Services
17277585 PROCESS FOR CONTROLLING A FERMENTATION PROCESS Non-Final OA FermentationExperts A/S
17285539 CORYNEFORM BACTERIA FOR PROVISION OF MALONYL-COA Final Rejection Forschungszentrum Jülich GmbH
17270690 Method for Producing Biodegradable Polymer Final Rejection MOHARRAM VENTURES INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month